83) ind of drug to the characteristics of the patient. |
84) heads has been described in the diabetic patient. |
85) should be planned for proper care of the patient. |
86) and sensory nerves of the upper arms of a patient. |
87) sure of pericardium and ribs in a Chinese patient. |
88) ufficient rotation at the cleft side in 1 patient. |
89) to respiratory mechanics in the pregnant patient. |
90) laboratory disorders were detected in the patient. |
91) are specifically suited to the individual patient. |
92) dministered with complete recovery of the patient. |
93) s, treatment alternatives, physician, and patient. |
94) e in selected situations, such as for our patient. |
95) y of the culprit artery in all except one patient. |
96) e incorporation of multiple endpoints per patient. |
97) ing even in a double antiplatelet therapy patient. |
98) mical location of the wound or age of the patient. |
99) se and the context of the surgery and the patient. |
100) -resistant Nocardia abscessus in a cancer patient. |
101) igh-dose Kalimate in a 59-year-old female patient. |
102) acid was immediately discontinued in this patient. |
103) Patient and physician acceptability for th |
104) nificant differences (P > .05) between patient and control groups in the levels o |
105) ous leg ulcer slough is unpleasant to the patient and difficult to manage clinically |
106) articular synovitis was reduced in every patient and disappeared in 2 patients. |
107) vidence currently available that explores patient and family caregiver resilience fo |
108) physical and psychological morbidity and patient and family caregiver resilience fo |
109) ulism had a great emotional impact on the patient and psychological support was cruc |
110) nvolvement of the breast by NHL in a male patient and the ultrasound imaging finding |
111) using the reconstructed anatomy for each patient and these models were analysed for |
112) critical care units typify the high-risk patient and they often require more device |
113) of radioactive tracer administered to the patient and to a total acquisition time co |
114) agnosis of HCC, but also in prediction of patient and treatment outcomes and individ |
115) must be individualized, tailored to each patient, and constantly re-evaluated and r |
|